COVID-19患者肠系膜缺血:75例腹部CT表现的最新系统综述
该系统综述纳入47项研究共75例COVID-19合并急性肠系膜缺血患者,评估腹部CT影像特征。最常见CT诊断为小肠缺血(46.67%),其次为缺血性结肠炎(37.3%);非闭塞性肠系膜缺血(NOMI)占67.9%,为最常见肠管受累模式。接受保守/内科治疗者死亡率为50%,提示无手术干预时死亡率高。
要点
- COVID-19合并急性肠系膜缺血最常见的CT诊断为小肠缺血(46.67%),其次为缺血性结肠炎(37.3%)。
- 非闭塞性肠系膜缺血(NOMI)占67.9%,提示微血管受累为最常见肠管受累模式。
- 肠壁增厚/水肿(50.9%)比肠管低灌注(20.7%)更常见。
核心结论
- 在COVID-19合并急性肠系膜缺血患者中,小肠缺血是最常见影像诊断,NOMI是最常见肠管受累模式;增强CT是快速诊断的有力决策工具,可能改善治疗时间和临床结局。
研究设计与样本
- 系统综述,检索Pubmed、EMBASE、WHO数据库和Google Scholar四个数据库,纳入47项研究共75例患者。
关键影像表现/征象
- 小肠缺血(46.67%)是最常见腹部CT表现,其次为缺血性结肠炎(37.3%)。
- 非闭塞性肠系膜缺血(NOMI;67.9%)为最常见肠管受累模式,提示微血管受累。
- 肠壁增厚/水肿(50.9%)比肠管低灌注(20.7%)更常见。
- 回肠和结肠受累比例相同(各32.07%),最常累及动脉为肠系膜上动脉(SMA;24.9%)、静脉为肠系膜上静脉(SMV;14.3%)、实质器官为脾脏(12.5%)。
- 剖腹探查和组织病理学所见与CT影像表现高度一致。
临床应用与阅片要点
- 增强CT是COVID-19患者急性肠系膜缺血快速诊断的有力决策工具,可能改善治疗时间和临床结局。
- 接受保守/内科治疗的患者50%死亡,提示无手术干预时死亡率高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Acute mesenteric ischemia (AMI) is a less common but devastating complication of COVID-19 disease. The aim of this systematic review was to assess the most common CT imaging features of AMI in COVID-19 and also provide an updated review of the literature on symptoms, treatment, histopathological and operative findings, and follow-up of these patients.
METHODS: A systematic literature search of four databases: Pubmed, EMBASE, WHO database, and Google Scholar, was performed to identify all the articles which described abdominal CT imaging findings of AMI in COVID-19.
RESULTS: A total of 47 studies comprising 75 patients were included in the final review. Small bowel ischemia (46.67%) was the most prevalent abdominal CT finding, followed by ischemic colitis (37.3%). Non-occlusive mesenteric ischemia (NOMI; 67.9%) indicating microvascular involvement was the most common pattern of bowel involvement. Bowel wall thickening/edema (50.9%) was more common than bowel hypoperfusion (20.7%). While ileum and colon both were equally involved bowel segments (32.07% each), SMA (24.9%), SMV (14.3%), and the spleen (12.5%) were the most commonly involved artery, vein, and solid organ, respectively. 50% of the patients receiving conservative/medical management died, highlighting high mortality without surgery. Findings on laparotomy and histopathology corroborated strikingly with CT imaging findings.
CONCLUSION: In COVID-19 patients with AMI, small bowel ischemia is the most prevalent imaging diagnosis and NOMI is the most common pattern of bowel involvement. Contrast-enhanced CT is a powerful decision-making tool for prompt diagnosis of AMI in COVID-19, thereby potentially improving time to treat as well as clinical outcomes.
引用
- Ojha V, Mani A, Mukherjee A, et al. Mesenteric ischemia in patients with COVID-19: an updated systematic review of abdominal CT findings in 75 patients. Abdom Radiol (NY). 2021. PMID: 34761305. doi:10.1007/s00261-021-03337-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。